Advertisement

Comprehensive Urine Drug Screen by Gas Chromatography/Mass Spectrometry (GC/MS)

  • Bheemraj Ramoo
  • Melissa Funke
  • Clint Frazee
  • Uttam GargEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1383)

Abstract

Drug screening is an essential component of clinical toxicology laboratory service. Some laboratories use only automated chemistry analyzers for limited screening of drugs of abuse and few other drugs. Other laboratories use a combination of various techniques such as immunoassays, colorimetric tests, and mass spectrometry to provide more detailed comprehensive drug screening. Mass spectrometry, gas or liquid, can screen for hundreds of drugs and is often considered the gold standard for comprehensive drug screening. We describe an efficient and rapid gas chromatography/mass spectrometry (GC/MS) method for comprehensive drug screening in urine which utilizes a liquid–liquid extraction, sample concentration, and analysis by GC/MS.

Key words

Toxicology GC/MS Drug analysis Comprehensive drug screening Drug screening 

References

  1. 1.
    Garg U, Frazee CC, Scott D, Wasserman G (2004) Comprehensive toxicology drug screening data in a pediatric population. J Toxicol Clin Toxicol 42:681–683CrossRefPubMedGoogle Scholar
  2. 2.
    Greller HA, Barrueto F Jr (2004) Comprehensive drug screening. Emerg Med J 21:646PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Griffiths WC, Oleksyk SK, Diamond I (1973) A comprehensive gas chromatographic drug screening procedure for the clinical laboratory. Clin Biochem 6:124–131CrossRefPubMedGoogle Scholar
  4. 4.
    Valli A, Polettini A, Papa P, Montagna M (2001) Comprehensive drug screening by integrated use of gas chromatography/mass spectrometry and Remedi HS. Ther Drug Monit 23:287–294CrossRefPubMedGoogle Scholar
  5. 5.
    Maurer HH (2006) Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom 41:1399–1413CrossRefPubMedGoogle Scholar
  6. 6.
    Fabbri A, Marchesini G, Morselli-Labate AM, Ruggeri S, Fallani M, Melandri R, Bua V, Pasquale A, Vandelli A (2003) Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose. Emerg Med J 20:25–28PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Kamel A, Prakash C (2006) High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology. Curr Drug Metab 7:837–852CrossRefPubMedGoogle Scholar
  8. 8.
    Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54–65CrossRefPubMedGoogle Scholar
  9. 9.
    Aebi B, Bernhard W (2002) Advances in the use of mass spectral libraries for forensic toxicology. J Anal Toxicol 26:149–156CrossRefPubMedGoogle Scholar
  10. 10.
    Lee YW (2013) Simultaneous screening of 177 drugs of abuse in urine using ultra-performance liquid chromatography with tandem mass spectrometry in drug-intoxicated patients. Clin Psychopharmacol Neurosci 11:158–164PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Remane D, Wetzel D, Peters FT (2014) Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Anal Bioanal Chem 406:4411–4424CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Bheemraj Ramoo
    • 1
  • Melissa Funke
    • 1
  • Clint Frazee
    • 1
  • Uttam Garg
    • 1
    Email author
  1. 1.Department of Pathology and Laboratory MedicineChildren’s Mercy Hospitals and ClinicsKansas CityUSA

Personalised recommendations